Literature DB >> 17904463

Diagnostic evaluation of mononucleosis-like illnesses.

Christopher Hurt1, Dominick Tammaro.   

Abstract

Clinicians face a diagnostic challenge when a patient with the classic fever, pharyngitis, and lymphadenopathy triad of infectious mononucleosis has a negative "spot" heterophile antibody test. This screening test, although commonly considered sensitive for the presence of Epstein-Barr virus (EBV) infection, may be negative early after infection. A growing number of pathogens have been reported to cause heterophile-negative mononucleosis-like illnesses, including cytomegalovirus (CMV), human herpesvirus 6 (HHV-6), human immunodeficiency virus (HIV), adenovirus, herpes simplex virus (HSV), Streptococcus pyogenes, and Toxoplasma gondii. Other infectious and noninfectious disorders also may present in ways that mimic mononucleosis, but fail to generate EBV's archetypal triad of clinical findings. A systematic approach to the diagnosis of mononucleosis-like illnesses ensures that conditions warranting specific therapy are distinguished from others requiring only supportive care.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904463     DOI: 10.1016/j.amjmed.2006.12.011

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  31 in total

1.  Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status.

Authors:  J Lupo; R Germi; T Semenova; M Buisson; J M Seigneurin; P Morand
Journal:  Clin Vaccine Immunol       Date:  2012-04-25

2.  Seroprevalence of Toxoplasma gondii in southern districts of Tamil Nadu using IgG-ELISA.

Authors:  G Sucilathangam; N Palaniappan; C Sreekumar; T Anna
Journal:  J Parasit Dis       Date:  2012-03-13

Review 3.  Selected topics on lymphoid lesions in the head and neck regions.

Authors:  Wesley O Greaves; Sa A Wang
Journal:  Head Neck Pathol       Date:  2011-02-03

4.  Application of a commercial immunoblot to define EBV IgG seroprofiles.

Authors:  Fernando de Ory; Eulalia Guisasola; David Tarragó; Juan Carlos Sanz
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

5.  Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin M.

Authors:  Mario Berth; Eugene Bosmans
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

6.  Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections.

Authors:  Fernando de Ory; María Eulalia Guisasola; Juan Carlos Sanz; Isabel García-Bermejo
Journal:  Clin Vaccine Immunol       Date:  2010-12-29

7.  Epstein-barr virus infection masquerading as acute leukemia: a report of two cases and review of literature.

Authors:  Puneet Chhabra; Arjun Dutt Law; Upender Sharma; Vikas Suri; Manupdesh Singh Sachdeva; Savita Kumari; Subhash Varma; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2012-10-25       Impact factor: 0.900

Review 8.  Cytomegalovirus related fatal duodenal diverticular bleeding: Case report and literature review.

Authors:  Jasbir Makker; Bharat Bajantri; Sailaja Sakam; Sridhar Chilimuri
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

9.  Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis.

Authors:  Alvaro Guerrero-Ramos; Mauli Patel; Kinjal Kadakia; Tanzina Haque
Journal:  Clin Vaccine Immunol       Date:  2014-04-02

10.  Cytomegalovirus infection-associated fulminant hepatitis in an immunocompetent adult requiring emergency living-donor liver transplantation: report of a case.

Authors:  Young-Dong Yu; Gil-Chun Park; Pyoung-Jae Park; Young-Il Choi; Shin Hwang; Gi-Won Song; Dong-Hwan Jung; Chul-Soo Ahn; Ki-Hun Kim; Deog-Bok Moon; Tae-Yong Ha; Sung-Gyu Lee
Journal:  Surg Today       Date:  2012-07-14       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.